Updated data on Endocyte's two lead product candidates to be presented at ASCO; shares up 16% after hours [Seeking Alpha]
ENDOCYTE (ECYT)
Last endocyte earnings: 11/7 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.endocyte.com/investor-relations
Company Research
Source: Seeking Alpha
Thinly traded micro cap Endocyte (NASDAQ: ECYT ) jumps after hours on light volume on the heels of its announcement that updated data on top candidates EC1456 and EC1169 will be presented at ASCO. EC1456: results from a two-part Phase 1 study, EC1456-01. Part A (dose escalation phase) involves 87 patients with advanced solid tumors and Part B (expansion phase) six patients with FR-positive non-small lung cancer as of the May 18 cutoff. Preliminary data on the first patient enrolled in the ovarian surgical study, EC1456-02, will also be presented (Abstract #2576). EC1169: results from a two-part Phase 1 (same design as EC1456-01) in patients with metastatic castration-resistant prostate cancer. Data includes 24 taxane-exposed patients in Part A and 16 taxane-naive patients in Part B (Abstract #5038). Now read: Johnson & Johnson (JNJ) Investor Presentation (Pharmaceutical Business Review Day) - Slideshow »
Show less
Read more
Impact Snapshot
Event Time:
ECYT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ECYT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ECYT alerts
High impacting ENDOCYTE news events
Weekly update
A roundup of the hottest topics